|
PLEKHA2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.562800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
8.37989999946664E-07 |
| Normal-vs-Stage2 |
6.084300E-02 |
| Normal-vs-Stage3 |
2.506400E-01 |
| Normal-vs-Stage4 |
3.500000E-01 |
| Stage1-vs-Stage2 |
6.587900E-02 |
| Stage1-vs-Stage3 |
1.719980E-01 |
| Stage1-vs-Stage4 |
5.649500E-02 |
| Stage2-vs-Stage3 |
8.424600E-01 |
| Stage2-vs-Stage4 |
6.665000E-01 |
| Stage3-vs-Stage4 |
8.771800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.219000E-04 |
| Normal-vs-AfricanAmerican |
4.320200E-03 |
| Normal-vs-Asian |
1.042350E-02 |
| Caucasian-vs-AfricanAmerican |
6.906400E-01 |
| Caucasian-vs-Asian |
4.666200E-01 |
| AfricanAmerican-vs-Asian |
4.223400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.44130000051734E-07 |
| Normal-vs-Female |
1.013390E-01 |
| Male-vs-Female |
8.682500E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.002300E-03 |
| Normal-vs-Extreme_Weight |
4.64310000447554E-08 |
| Normal-vs-Obese |
4.228100E-02 |
| Normal-vs-Extreme_Obese |
2.061500E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.014600E-01 |
| Normal_Weight-vs-Obese |
3.035600E-01 |
| Normal_Weight-vs-Extreme_Obese |
4.844000E-01 |
| Extreme_Weight-vs-Obese |
3.135800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
8.147000E-01 |
| Obese-vs-Extreme_Obese |
8.068000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.609000E-01 |
| Normal-vs-Age(41-60Yrs) |
3.638300E-04 |
| Normal-vs-Age(61-80Yrs) |
2.74050000026449E-07 |
| Normal-vs-Age(81-100Yrs) |
1.283370E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.488200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.673900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.608100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.290500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.158800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.283800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.64659999868766E-08 |
| Normal-VS-Type2 PRCC |
2.74290000001898E-06 |
| Normal-VS-KIRP CIMP |
5.230400E-02 |
| Normal-VS-Unclassified PRCC |
3.152300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
4.983800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
7.918500E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
1.551220E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.983500E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
7.062200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
1.484460E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.89020999999956E-05 |
| Normal-vs-N1 |
6.524000E-01 |
| Normal-vs-N2 |
6.601000E-01 |
| N0-vs-N1 |
1.720290E-02 |
| N0-vs-N2 |
1.314200E-01 |
| N1-vs-N2 |
6.929600E-01 |
|
|
